Antibody responses to SARS-CoV-2 in patients with COVID-19

doi:10.1038/s41591-020-0897-1

. 2020 Jun;26(6):845-848.

doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.

Antibody responses to SARS-CoV-2 in patients with COVID-19

Quan-Xin Long^#¹, Bai-Zhong Liu^#², Hai-Jun Deng^#¹, Gui-Cheng Wu^#^{3

4}, Kun Deng^#⁵, Yao-Kai Chen^#⁶, Pu Liao⁷, Jing-Fu Qiu⁸, Yong Lin¹, Xue-Fei Cai¹, De-Qiang Wang¹, Yuan Hu¹, Ji-Hua Ren¹, Ni Tang¹, Yin-Yin Xu², Li-Hua Yu², Zhan Mo², Fang Gong², Xiao-Li Zhang², Wen-Guang Tian², Li Hu², Xian-Xiang Zhang^{3

4}, Jiang-Lin Xiang^{3

4}, Hong-Xin Du^{3

4}, Hua-Wen Liu^{3

4}, Chun-Hui Lang^{3

4}, Xiao-He Luo^{3

4}, Shao-Bo Wu^{3

4}, Xiao-Ping Cui^{3

4}, Zheng Zhou^{3

4}, Man-Man Zhu⁵, Jing Wang⁶, Cheng-Jun Xue⁶, Xiao-Feng Li⁶, Li Wang⁶, Zhi-Jie Li⁷, Kun Wang⁷, Chang-Chun Niu⁷, Qing-Jun Yang⁷, Xiao-Jun Tang⁸, Yong Zhang⁸, Xia-Mao Liu⁹, Jin-Jing Li⁹, De-Chun Zhang¹⁰, Fan Zhang¹⁰, Ping Liu¹¹, Jun Yuan¹, Qin Li¹², Jie-Li Hu¹³, Juan Chen¹⁴, Ai-Long Huang¹⁵

Affiliations

¹ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China.
² Yongchuan Hospital Affiliated to Chongqing Medical University, Chongqing, China.
³ Chongqing University Three Gorges Hospital, Chongqing, China.
⁴ Chongqing Three Gorges Central Hospital, Chongqing, China.
⁵ The Third Hospital Affiliated to Chongqing Medical University, Chongqing, China.
⁶ Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China.
⁷ Laboratory Department, Chongqing People's Hospital, Chongqing, China.
⁸ School of Public Health and Management, Chongqing Medical University, Chongqing, China.
⁹ The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
¹⁰ Wanzhou People's Hospital, Chongqing, China.
¹¹ BioScience Co. Ltd, Chongqing, China.
¹² Chongqing Center for Disease Control and Prevention, Chongqing, China.
¹³ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China. 102564@cqmu.edu.cn.
¹⁴ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China. chenjuan2014@cqmu.edu.cn.
¹⁵ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China. ahuang@cqmu.edu.cn.

^# Contributed equally.

PMID: 32350462
DOI: 10.1038/s41591-020-0897-1

Antibody responses to SARS-CoV-2 in patients with COVID-19

Quan-Xin Long et al. Nat Med. 2020 Jun.

. 2020 Jun;26(6):845-848.

doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.

Authors

Affiliations

¹ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China.
² Yongchuan Hospital Affiliated to Chongqing Medical University, Chongqing, China.
³ Chongqing University Three Gorges Hospital, Chongqing, China.
⁴ Chongqing Three Gorges Central Hospital, Chongqing, China.
⁵ The Third Hospital Affiliated to Chongqing Medical University, Chongqing, China.
⁶ Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China.
⁷ Laboratory Department, Chongqing People's Hospital, Chongqing, China.
⁸ School of Public Health and Management, Chongqing Medical University, Chongqing, China.
⁹ The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
¹⁰ Wanzhou People's Hospital, Chongqing, China.
¹¹ BioScience Co. Ltd, Chongqing, China.
¹² Chongqing Center for Disease Control and Prevention, Chongqing, China.
¹³ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China. 102564@cqmu.edu.cn.
¹⁴ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China. chenjuan2014@cqmu.edu.cn.
¹⁵ Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China. ahuang@cqmu.edu.cn.

^# Contributed equally.

PMID: 32350462
DOI: 10.1038/s41591-020-0897-1

Abstract

We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within 19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G (IgG). Seroconversion for IgG and IgM occurred simultaneously or sequentially. Both IgG and IgM titers plateaued within 6 days after seroconversion. Serological testing may be helpful for the diagnosis of suspected patients with negative RT-PCR results and for the identification of asymptomatic infections.

PubMed Disclaimer

Cited by

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
Xiao N, Nie M, Pang H, Wang B, Hu J, Meng X, Li K, Ran X, Long Q, Deng H, Chen N, Li S, Tang N, Huang A, Hu Z. Xiao N, et al. Nat Commun. 2021 Mar 12;12(1):1618. doi: 10.1038/s41467-021-21907-9. Nat Commun. 2021. PMID: 33712622 Free PMC article.
Antibody Levels Poorly Reflect on the Frequency of Memory B Cells Generated following SARS-CoV-2, Seasonal Influenza, or EBV Infection.
Wolf C, Köppert S, Becza N, Kuerten S, Kirchenbaum GA, Lehmann PV. Wolf C, et al. Cells. 2022 Nov 18;11(22):3662. doi: 10.3390/cells11223662. Cells. 2022. PMID: 36429090 Free PMC article.
SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology.
Sahu AK, Sreepadmanabh M, Rai M, Chande A. Sahu AK, et al. Virusdisease. 2021 Mar;32(1):1-12. doi: 10.1007/s13337-021-00653-y. Epub 2021 Feb 22. Virusdisease. 2021. PMID: 33644261 Free PMC article. Review.
Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients.
Pflüger LS, Bannasch JH, Brehm TT, Pfefferle S, Hoffmann A, Nörz D, van der Meirschen M, Kluge S, Haddad M, Pischke S, Hiller J, Addo MM, Lohse AW, Schulze Zur Wiesch J, Peine S, Aepfelbacher M, Lütgehetmann M. Pflüger LS, et al. J Clin Virol. 2020 Sep;130:104549. doi: 10.1016/j.jcv.2020.104549. Epub 2020 Jul 17. J Clin Virol. 2020. PMID: 32763809 Free PMC article.
Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.
Hu J, Gao Q, He C, Huang A, Tang N, Wang K. Hu J, et al. Genes Dis. 2020 Dec;7(4):551-557. doi: 10.1016/j.gendis.2020.07.006. Epub 2020 Jul 17. Genes Dis. 2020. PMID: 32837985 Free PMC article.

See all "Cited by" articles

References

1. Corman, V. M. et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 62, 477–483 (2016). - PubMed
1. Li, G., Chen, X. & Xu, A. Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349, 508–509 (2003). - DOI
1. Hsueh, P. R., Huang, L. M., Chen, P. J., Kao, C. L. & Yang, P. C. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin. Microbiol. Infect. 10, 1062–1066 (2004). - DOI
1. Park, W. B. et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg. Infect. Dis. 21, 2186–2189 (2015). - DOI
1. Drosten, C. et al. Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371, 828–835 (2014). - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

81672012/National Natural Science Foundation of China (National Science Foundation of China)/International

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database

[1] Corman, V. M. et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 62, 477–483 (2016). - PubMed

[2] Corman, V. M. et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 62, 477–483 (2016). - PubMed

[3] Li, G., Chen, X. & Xu, A. Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349, 508–509 (2003). - DOI

[4] Li, G., Chen, X. & Xu, A. Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349, 508–509 (2003). - DOI

[5] Hsueh, P. R., Huang, L. M., Chen, P. J., Kao, C. L. & Yang, P. C. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin. Microbiol. Infect. 10, 1062–1066 (2004). - DOI

[6] Hsueh, P. R., Huang, L. M., Chen, P. J., Kao, C. L. & Yang, P. C. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin. Microbiol. Infect. 10, 1062–1066 (2004). - DOI

[7] Park, W. B. et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg. Infect. Dis. 21, 2186–2189 (2015). - DOI

[8] Park, W. B. et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg. Infect. Dis. 21, 2186–2189 (2015). - DOI

[9] Drosten, C. et al. Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371, 828–835 (2014). - DOI

[10] Drosten, C. et al. Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371, 828–835 (2014). - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Antibody responses to SARS-CoV-2 in patients with COVID-19

Affiliations

Antibody responses to SARS-CoV-2 in patients with COVID-19

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources